Variantyx

About Variantyx

Variantyx is a molecular diagnostics company focused on providing genetic testing for rare genetic disorders, reproductive genetics, and precision oncology. Their mission is to improve patients' quality of life through state-of-the-art genomic tests and personalized medicine using advanced laboratory technology, proprietary AI/ML analytical tools, and a world-class clinical team.

Products & Services

Rare Genetic Disorders Testing:Comprehensive and targeted analyses for rare genetic disorders, including whole genome, exome, and specific gene panel tests such as Genomic Unity 2.0.

Neurology Analyses:Specialized tests for neurological conditions, including ataxia, epilepsy, and muscular dystrophy analyses.

Rapid Genome Testing:Fast genetic testing options for neonatal, pediatric, and standard cases.

Reproductive Genetics:Testing services like CNV and comprehensive prenatal analysis for reproductive health.

Precision Oncology:Tests for somatic and hereditary cancers, including solid tumor analysis and specific gene tests like BRCA1/2.

Wellness Testing:Proactive health testing such as Genomic Inform to provide personalized health insights.

Custom Analysis:Tailored genetic testing solutions for specific needs.

Specialties

Genetic Testing Rare Genetic Disorders Reproductive Genetics Precision Oncology Whole Genome Analysis AI/ML Analytical Tools

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity T: - FT: Equity	A: 36000000 MR: - FA: $36 million FAN: 36000000	D: 2024-04-26 FD: 2024-04-26	4 investors
2	RT: Additional Funding T: - FT: Additional Funding	A: 120000000 MR: - FA: over $120 million FAN: 120000000	D: 2023-10-18 FD: 2023-10-18	5 investors

Equity Latest

2024-04-26

$36.0M

4 investors (Pro only)

Additional Funding 2023-10-18

$120.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

N

Nitzan Stern Braun

Senior Business System Analyst

H

Haim Neerman

CEO

LinkedIn (Pro only)

J

Jeffrey Weisberg

CFO

LinkedIn (Pro only)

Y

Yaron Rachmany

COO

C

Christine Stanley

Chief Genomics and Compliance Officer

E

Eyal Reinstein

Chief Medical Officer

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Variantyx Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised